Research advances in vestibular migraine
10.19845/j.cnki.zfysjjbzz.2026.0065
- VernacularTitle:前庭性偏头痛的研究进展
- Author:
Lili ZHAO
1
;
Ligang JIANG
1
Author Information
1. Department of Neurology， Affiliated Hospital of Jilin Medical College， Jilin 132000， China
- Publication Type:Journal Article
- Keywords:
Vestibular migraine;
Trigeminal neurovascular system;
Cortical diffusion inhibition / Calcitonin gene-related peptide antagonist;
Vestibular rehabilitation training
- From:
Journal of Apoplexy and Nervous Diseases
2026;43(4):379-384
- CountryChina
- Language:Chinese
-
Abstract:
Vestibular migraine （VM） is the most common cause of recurrent vertigo， and it is an overlapping disease of central vestibular disease and migraine，as well as a syndrome characterized by the simultaneous or alternating occurrence of paroxysmal vestibular symptoms and typical migraine attacks.VM is known as the “chameleon of vestibular system diseases” due to its complex and diverse symptoms， which can easily lead to missed diagnosis and misdiagnosis. In recent years， with the development of neuroimaging technology and the implementation of multi-center clinical research， the pathogenesis of VM has gradually been expanded from the classic trigeminal neurovascular theory to the aspects of neurotransmitter disorder，cortical diffusion inhibition，and abnormal vestibular-cortical pathway integration. In addition， there have been constant improvements in the diagnosis system of VM，and the treatment modality of VM is gradually shifting to the comprehensive treatment paradigm of “symptomatic treatment in the acute stage combined with preventive treatment in the remission stage and lifestyle adjustment”.This article reviews the latest research advances in this field.
- Full text:2026061215044213814前庭性偏头痛的研究进展.pdf
